Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer.

Autor: Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC, Annunziata, Christina M, Stavnes, Helene Tuft, Kleinberg, Lilach, Berner, Aasmund, Hernandez, Lidia F, Birrer, Michael J, Steinberg, Seth M, Davidson, Ben, Kohn, Elise C

Publikováno v: Cancer (0008543X); 7/1/2010, Vol. 116 Issue 13, p3276-3284, 9p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer.

Autor: Jaiswal SK; Translational and Functional Genomics Branch, National Human Genome Research Institute, Bethesda, MD 20892., Fedkenheuer K; Translational and Functional Genomics Branch, National Human Genome Research Institute, Bethesda, MD 20892., Khamar R; Translational and Functional Genomics Branch, National Human Genome Research Institute, Bethesda, MD 20892., Tan H; Translational and Functional Genomics Branch, National Human Genome Research Institute, Bethesda, MD 20892., Gotea V; Translational and Functional Genomics Branch, National Human Genome Research Institute, Bethesda, MD 20892., Raj S; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD 20892., Fedkenheuer M; Genomics and Immunity Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892., Elkahloun A; Microarrays and Single-Cell Genomics Core, National Human Genome Research Institute, Bethesda, MD 20892., Zhao M; HPLC Core, National Institute of Allergy and Infectious Diseases, Rockville, MD 20852., Jenkins LM; Mass Spec Core, National Cancer Institute, Bethesda, MD 20892., Annunziata CM; Women's Malignancies Branch, National Cancer Institute, Bethesda, MD 20892., Elnitski L; Translational and Functional Genomics Branch, National Human Genome Research Institute, Bethesda, MD 20892. Electronic address: Elnitski@nih.gov.

Publikováno v: Cancer letters [Cancer Lett] 2024 Jul 22, pp. 217129. Date of Electronic Publication: 2024 Jul 22.

Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer.

Autor: Kudo K; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Tohoku University School of Medicine, Miyagi, Japan., Greer YE; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yoshida T; Kidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA., Harrington BS; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Korrapati S; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Shibuya Y; Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Tohoku University School of Medicine, Miyagi, Japan., Henegar L; Karyopharm Therapeutics, Newton, MA, USA., Kopp JB; Kidney Disease Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA., Fujii T; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Lipkowitz S; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Annunziata CM; Women's Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. christina.annunziata@cancer.org.

Publikováno v: Cancer gene therapy [Cancer Gene Ther] 2024 May; Vol. 31 (5), pp. 721-735. Date of Electronic Publication: 2024 Feb 29.